Incyte, Novartis drug shows promise for pancreatic cancer
This article was originally published in Scrip
Executive Summary
Incyte's blood cancer drug Jakafi improved survival in pancreatic cancer patients in a study, giving hope that the therapy can be effective treating solid tumors.